CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,856,253 | -8.3% | 1,002,783 | +5.2% | 1.26% | +41.9% |
| Q3 2022 | $6,384,000 | +123.2% | 952,783 | +40.2% | 0.89% | +189.5% |
| Q2 2022 | $2,860,000 | -41.1% | 679,400 | +76.9% | 0.31% | -29.0% |
| Q4 2020 | $4,854,000 | +59.5% | 384,039 | +23.9% | 0.43% | +44.1% |
| Q3 2020 | $3,044,000 | -56.3% | 310,000 | -55.8% | 0.30% | -54.4% |
| Q2 2020 | $6,972,000 | -22.1% | 700,710 | -30.8% | 0.66% | -41.4% |
| Q1 2020 | $8,955,000 | +593.1% | 1,013,039 | +623.6% | 1.12% | +956.6% |
| Q4 2019 | $1,292,000 | +57.0% | 140,000 | 0.0% | 0.11% | -16.5% |
| Q3 2019 | $823,000 | -75.9% | 140,000 | -22.2% | 0.13% | -74.6% |
| Q4 2015 | $3,415,000 | -9.0% | 180,000 | -10.0% | 0.50% | +4.4% |
| Q3 2015 | $3,754,000 | +1490.7% | 200,000 | +1161.2% | 0.48% | +1982.6% |
| Q2 2015 | $236,000 | -95.8% | 15,858 | -95.8% | 0.02% | -96.1% |
| Q1 2015 | $5,679,000 | +184.2% | 375,000 | +150.0% | 0.59% | +73.8% |
| Q4 2014 | $1,998,000 | +598.6% | 150,000 | +560.8% | 0.34% | +871.4% |
| Q3 2014 | $286,000 | – | 22,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |